Embryo quality is the main factor affecting cumulative live birth rate after elective single embryo transfer in fresh stimulation cycles by Niinimaki, Maarit et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology 194 (2015) 131–135Embryo quality is the main factor affecting cumulative live birth rate
after elective single embryo transfer in fresh stimulation cycles
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A B S T R A C T
Objective: The study was aimed to evaluate which factors affect the cumulative live birth rate after
elective single embryo transfer in women younger than 36 years. Additionally, number of children in
women with more than one delivery per ovum pick-up after fresh elective single embryo transfer and
subsequent frozen embryo transfers was assessed.
Study design: Retrospective cohort study analysing data of a university hospital’s infertility clinic in
2001–2010. A total of 739 IVF/ICSI cycles with elective single embryo transfer were included. Analyses
were made per ovum pick-up including fresh and subsequent frozen embryo transfers. Factors affecting
cumulative live birth rates were examined in uni- and multivariate analyses. A secondary endpoint was
the number of children born after all treatments.
Results: In the fresh cycles, the live birth rate was 29.2% and the cumulative live birth rate was 51.3%,
with a twin rate of 3.4%. In the multivariate analysis, having two (odds ratio (OR) 1.73; 95% confidence
interval (CI) 1.12–2.67) or 3 top embryos (OR 2.66; 95% CI 1.79–3.95) was associated with higher odds
for live birth after fresh and frozen embryo cycles. Age, body mass index, duration of infertility, diagnosis
or total gonadotropin dose were not associated with the cumulative live birth rate. In cycles with one top
embryo, the cumulative live birth rate was 40.2%, whereas it was 64.1% in those with at least three top
embryos. Of women who had a live birth in the fresh cycle, 20.4% had more than one child after all frozen
embryo transfers. Among women with three or more top embryos after ovum pick-up, 16.1% gave birth
to more than one child.
Conclusion: The cumulative live birth rate in this age group varies from 40% to 64% and is dependent on
the quality of embryos. Women with three or more top embryos have good chance of having more than
one child per ovum pick-up without elevated risk of multiple pregnancies.
 2015 Elsevier Ireland Ltd. All rights reserved.
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In in vitro fertilisation (IVF) or intracytoplasmic sperm injection
(ICSI), elective single embryo transfer (eSET) is an effective method
to decrease multiple births which cause increased maternal and
perinatal morbidity and mortality [1]. Largely due to the introduc-
tion of eSET, the multiple delivery rate per embryo transfer has
declined steadily in Europe from 26.9% in 2000 to 19.2% in 2010
[1]. eSET is widely practiced in the Nordic countries. Accordingly,* Corresponding author at: Department of Obstetrics and Gynecology, Oulu
University Hospital, P.O. Box 24, 90029 Oulu, Finland. Tel.: +358 503371922.
E-mail address: maarit.niinimaki@oulu.fi (M. Niinimäki).
http://dx.doi.org/10.1016/j.ejogrb.2015.08.031
0301-2115/ 2015 Elsevier Ireland Ltd. All rights reserved.statistics from 2011 show a low proportion of multiple births after
IVF/ICSI – from 5.1% (Sweden) to 16.5% (Denmark) [2].
Embryo freezing is an essential component of eSET policy. Frozen
embryo transfer (FET) cycles account for 31.8% of all assisted
reproduction technology (ARTs) in the Nordic countries. The rate is
highest in Finland (45.1%) [2]. Previous studies have confirmed that
the cumulative pregnancy and live birth rates (cLBR) evaluating the
outcome of ovum pick-up (OPU) and all following FETs indicate the
real efficiency of ART and should be used when compared with other
transfer policies [3,4]. eSET, combined with an effective cryopres-
ervation programme, has been shown to result in a high cumulative
pregnancy rate (44–62%) per oocyte retrieval [5–8]. The success in
IVF treatment has been shown to have association with morpho-
logical parameters of the embryo [9]. On the other hand, a recent
study indicated that embryo quality has no effect on maternal or
M. Niinimäki et al. / European Journal of Obstetrics & Gynecology and Reproductive Biology 194 (2015) 131–135132neonatal outcomes in SET cycles [10]. There are few studies on
factors affecting cumulative outcomes in eSET cycles.
According to earlier analyses, eSET diminished the costs in the
general IVF/ICSI population [11], especially among women aged
36 years or less [12]. Studies comparing cLBR in eSET and double
embryo transfer (DET) cycles in older women also suggest eSET is a
viable treatment option [13,14]. Currently, eSET is more commonly
applied to women younger than 36 years [1]. eSET has been
suggested as a treatment of choice in this age group, even in
countries with low eSET use [12,15].
The primary aim of the present study was to investigate the
factors that affect cLBR after eSET in a cohort of women younger
than 36 years. The results could be useful in counselling couples
undergoing infertility treatment. A secondary aim was to analyse
how many children were born in women with more than one
delivery after single IVF stimulation, including deliveries after eSET
in fresh cycle and subsequent FET cycles. This aspect has not been
studied previously, although from the point of view of the couples
information on the possible number of children gained with a
single stimulated cycle is undoubtedly important.
Materials and methods
This retrospective cohort study population consisted of all first
IVF/ICSI treatments with eSET performed in the fresh cycle on day
2 after ovum pick-up (ultrasound-guided oocyte aspiration underTable 1
Characteristics, N (%).
By the number of top embryos
All, N = 739 1 
Age (years)
Younger than 30 354 (47.9) 132 (37
30–35 385 (52.1) 154 (40
BMI (kg/m2)a
<20.0 97 (13.3) 42 (43
20.0–24.9 432 (59.0) 171 (39
25.0–29.9 140 (19.1) 51 (36
30.0–34.9 51 (7.0) 17 (33
35.0 or more 12 (1.6) 1 (8.3
Duration of infertility (years)b
Less than 1 9 (1.5) 1 (0.4
1–2 years 201 (32.6) 72 (30
3–4 years 247 (40.0) 105 (44
5 years or more 160 (25.9) 57 (24
Main diagnosis
Endometriosis 140 (18.9) 61 (21
Hormonal 69 (9.3) 16 (5.6
Tubal 89 (12.0) 38 (13
Male 232 (31.4) 90 (31
Unexplained 161 (21.8) 59 (20
Multiple & other reasons 48 (6.5) 22 (7.7
Type of ART
IVF 433 (58.6) 169 (59
ICSI or IVF + ICSI 306 (41.4) 117 (40
Gonadotropin dose IU (mean + SD) 1920 (659) 2051 (77
Number of oocytes
Less than 10 216 (29.2) 124 (43
10–20 419 (56.7) 140 (49
More than 20 104 (14.1) 22 (7.7
Number of embryos frozen
1–4 344 (46.5) 200 (69
5–10 321 (43.4) 78 (27
More than 10 74 (10.0) 8 (2.8
BMI, body mass index; ART, assisted reproductive technology.
IVF + ICSI, IVF and ICSI used in 50%/50% of the oocytes.
a Data missing in 7 cases (0.9%).
b Data missing in 122 cases (16.5%).intravenous sedation) in the time period 2001–2010 in Oulu
University Hospital, Department of Obstetrics and Gynaecology,
Oulu, Finland. eSET was defined as a treatment in which one
embryo was transferred in the fresh cycle and at least one embryo
was frozen. All subjects were younger than 36 years at the time of
OPU. The analyses were made per treatment (OPU). The study
consisted only of couples treated with their own gametes.
Cumulative analyses were carried out by identifying FET cycles
following OPU using the identification code in the Babe1 database
for ART patients (Cleodora Software, Portugal). In the FET cycles
one or two embryos were transferred at the time. As one of the key
issues was to determine the impact of the embryo quality on the
success rate, women with missing data on the quality of embryos
were excluded. Ovarian stimulation was mainly performed using
the long GnRH agonist protocol (93.0%, 688 cycles) or the GnRH
antagonist protocol (3.5%, 26 cycles). In 25 cycles (3.5%), other
stimulation protocols were used. The starting gonadotrophin dose
was determined according to the patient’s age, BMI, antral
follicular count in the baseline ultrasonographic scan and the
outcome of previous infertility treatments. A top quality embryo
had 4–5 evenly sized cells and <20% of fragmentation [9]. Embryos
not transferred in the fresh cycle were frozen on the day of embryo
transfer, using a slow freezing protocol.
Data on the woman’s age at the time of IVF or ICSI treatment,
body mass index (BMI) (kg/m2), duration of infertility at the time of
IVF or ICSI (years), main cause of infertility, number of oocytes2 3 or more p Value
.3) 80 (22.6) 142 (40.1) 0.22
.0) 100 (26.0) 131 (34.0)
.3) 22 (22.7) 33 (34.0) 0.06
.6) 100 (23.1) 161 (37.3)
.4) 32 (22.9) 57 (40.7)
.3) 15 (29.4) 19 (37.3)
) 8 (66.7) 3 (25.0)
) 1 (0.7) 7 (3.0) 0.04
.6) 42 (28.0) 87 (37.5)
.7) 63 (42.0) 79 (34.1)
.3) 44 (29.3) 59 (25.4)
.3) 29 (16.1) 50 (18.3) 0.09
) 21 (11.7) 32 (11.7)
.3) 14 (7.8) 37 (13.6)
.5) 57 (31.7) 85 (31.1)
.6) 45 (25.0) 57 (20.9)
) 14 (7.8) 12 (4.4)
.1) 103 (57.2) 161 (59.0) 0.92
.9) 77 (42.8) 112 (41.0)
6) 1865 (511) 1819 (586) <0.001
.4) 53 (29.4) 39 (14.3) <0.001
.0) 104 (57.8) 175 (64.1)
) 23 (12.8) 59 (21.6)
.9) 90 (50.0) 54 (19.8) <0.001
.3) 82 (45.6) 161 (59.0)
) 8 (4.4) 58 (21.2)
Table 2
Pregnancy outcomes, N (%).
By the number of top embryos
All (N = 739) 1 (N = 286) 2 (N = 180) 3 or more (N = 273) p Value
Clinical pregnancy 259 (35.0) 100 (35.0) 61 (33.9) 98 (35.9) 0.91
LBR/OPU 216 (29.2) 82 (28.7) 51 (28.3) 83 (30.4) 0.88
cLBR/OPU 379 (51.3) 115 (40.2) 89 (49.4) 175 (64.1) <0.001
Twins in fresh cycle 1 (0.1) 1 0 0
Twins in FET cycle 12 (1.6) 2 (0.7) 3 (1.7) 7 (2.6) 0.22
Number of children per OPU
1 303 (41.0) 99 (34.6) 72 (40.0) 132 (48.4) 0.23
2 64 (8.7)a 14 (4.9) 15 (8.3) 35 (12.8)
3 12 (1.6)b 2 (0.7) 2 (1.1) 8 (2.9)
LBR, live birth rate; cLBR, cumulative live birth rate; OPU, ovum pick-up; FET, frozen embryo transfer.
a Including 8 twin pairs.
b Including 4 twin pairs.
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total number of good quality embryos were retrospectively
collected. Clinical pregnancy was defined as a visible heartbeat
of the foetus in a transvaginal scan in the 6th to 8th week of
pregnancy, which is routinely offered to patients undergoing ART.
Data on the pregnancy outcome (live birth, spontaneous abortion,
ectopic pregnancy, induced abortion or stillbirth) were obtained
from the Babe1 database together with the number of children
born at the time and data on number of children born after a single
OPU and following FETs in women with more than one delivery.
Ethics committee of the local hospital district (Northern Ostro-
bothnia Hospital District) considered that approval of the
committee in not needed in local register study in which all
clinical information has been conducted as a retrospective auditTable 3
Results of the uni- and multivariate analysis for the cLBR/OPU.
Univariate 
OR (95% CI) 
Age
<30 1 (ref) 
30–35 0.83 (0.62–1.11) 
BMI (kg/m2)
<20.0 1.21 (0.77–1.91) 
20.0–24.9 1 (ref) 
25.0–29.9 0.72 (0.49–1.05) 
30.0–34.9 0.72 (0.40–1.29) 
35.0 0.63 (0.20–2.00) 
Duration of infertility
Less than 1 year 1.08 (0.28–4.15) 
1–2 years 0.99 (0.66–1.52) 
3–4 years 0.83 (0.56–1.23) 
> 4 years 1 (ref) 
Main diagnosis
Endometriosis 1 (ref) 
Male 1.07 (0.70–1.63) 
Tubal 1.03 (0.60–1.75) 
Hormonal 1.13 (0.63–2.01) 
Unexplained 0.86 (0.55–1.36) 
Multiple and other reasons 0.55 (0.28–1.08) 
Type of ART
IVF 1 (ref) 
ICSI or IVF + ICSI 1.10 (0.82–1.47) 
Gonadotropin dose 1.00 (1.00–1.00) 
Total number of good quality embryos
1 1 (ref) 
2 1.45 (0.99–2.19) 
3 or more 2.66 (1.89–3.74) 
BMI, body mass index; ART, assisted reproductive technology; ref, reference.and the patients have not been contacted for the purpose of this
study.
Table 1 shows patient characteristics and Table 2 presents the
pregnancy outcomes. The different groups were compared with a
chi-square test or Fisher’s exact test if >20% of parameters had a
value less than 5 (duration of infertility). A Kruskal–Wallis test was
performed for the statistical comparison of continuous parameters
with a skewed distribution (gonadotropin dose). Logistic regres-
sion was performed for each parameter (age, BMI, duration of
infertility, cause of infertility, type of ART, total dose of
gonadotropin and number of good quality embryos) in a univariate
analysis of cLBR (Table 3), and all the parameters in univariate
analysis were then added to a multivariate analysis model. As the
numbers of oocytes and frozen embryos showed dependence withMultivariate
p Value OR (95% CI) p Value
1 (ref)
0.21 0.82 (0.58–1.16) 0.26
0.41 1.35 (0.80–2.26) 0.26
1 (ref)
0.09 0.67 (0.43–1.05) 0.08
0.27 0.76 (0.39–1.47) 0.41
0.43 0.55 (0.15–2.05) 0.37
0.92 0.66 (0.16–2.69) 0.57
1.00 0.91 (0.58–1.42) 0.67
0.35 0.87 (0.58–1.35) 0.58
1 (ref)
1 (ref)
0.75 0.92 (0.53–1.58) 0.76
0.92 0.97 (0.52–1.82) 0.93
0.69 0.83 (0.42–1.63) 0.58
0.52 0.78 (0.46–1.32) 0.36
0.08 0.52 (0.22–1.19) 0.12
1 (ref)
0.54 1.05 (0.70–1.57) 0.81
0.04 1.0 (1.00–1.00) 0.40
1 (ref)
0.05 1.73 (1.12–2.67) 0.01
<0.001 2.66 (1.79–3.95) <0.001
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Table 1), they were left out of uni- and multivariate analysis
(Table 3). A p value less than 0.05 was considered statistically
significant. Analysis was performed using the IBM Statistical
Package for the Social Sciences software package, version 19.
Results
The final study population consisted of 739 women younger
than 36 years who underwent eSET cycles in 2001–2010. Eleven
cycles were excluded due to missing data on embryo quality.
Characteristics of the fresh cycles are shown in Table 1. The mean
age of the patients was 29.6 years (range 20–35 years). The most
common causes of infertility were male factor (31.4%), unex-
plained infertility (21.8%) and endometriosis (18.9%). BMI, the total
gonadotropin dose and the number of oocytes retrieved differed
between the groups.
The pregnancy outcomes are shown in Table 2. The clinical
pregnancy rate in the fresh cycles was 35.0%. Of these clinical
pregnancies, 83.4% ended in live birth and 13.1% in miscarriage.
The live birth rate in the fresh cycles was 29.2%. The cLBR per OPU
was 51.3%. The cLBR significantly increased with a higher number
of top embryos. In the OPUs with one top embryo, 40.2% had at
least one live birth following a fresh cycle and all performed FET
cycles. In cases with two good quality embryos, the cLBR was
49.4%. In those with three or more good quality embryos, the cLBR
was 64.1% (p < 0.001).
In the fresh eSET cycle, one monochorionic twin pregnancy
occurred. In the FET cycles altogether, 12 twin pairs were
diagnosed following the transfer of two embryos. The cumulative
twin rate was 3.4%. In the whole cohort, 303 (41.0%) OPUs resulted
in the birth of one child, 64 (8.7%) OPUs – in the birth of two
children, including one twin pair in a fresh cycle and seven twin
pairs in FET cycles, and 12 (1.6%) OPUs resulted in the birth of three
children, including four twin pairs in FET cycles. There were
217 children (46.4%) born after the fresh transfers, and 250
children (53.5%) were born after FET (467 children born altogeth-
er). In cases with a live birth in a fresh cycle (n = 216), 39 (18.1%)
resulted in the birth of two children and 5 (2.3%) OPUs in the birth
of three children when a fresh cycle and FETs were all counted.
In the univariate logistic regression (Table 3) for the cLBR per
OPU gonadotropin dose and the number of top embryos were
significant. All parameters were included in a multivariate analysis
(Table 3). In the multivariate analysis, having two (OR 1.73; 95%
confidence interval (CI) 1.12–2.67) or three or more top embryos
(OR 2.66; 95% CI 1.79–3.95) increased the odds for cumulative
live birth.
Comment
Among the parameters analysed, embryo quality was the most
important determinant of the cLBR per oocyte retrieval in eSET
cycles. Of women with three or more good quality embryos, a high
proportion (63.8%) achieved a live birth. These results show that
well-functioning cryopreservation policy plays an important role,
as 53.5% of the children were born after the transfer of thawed
embryos. In the Nordic countries FET is an essential part of eSET
practice and the proportion of FET cycles is high. According to
Nordic statistics in 2011, the cLBR is highest in Finland (33.7%)
when compared to other Nordic countries (25.4% in Denmark,
26.9% in Norway and 31.2% in Sweden), probably reflecting the
highest number of FET cycles performed in Finland [2]. The present
results are in line with the findings of a smaller Swedish study
comparing cumulative live birth rates in SET or DET [16] although
in their study the cumulative live birth rates were evidently lower(34.8% in the first fresh SET cycle and 32.2% in the second fresh
cycle) than in the present study (51.3%) [16].
The number of children born after single OPU and following FET
cycles in eSET has not been reported in earlier literature. Of women
having favourable response to stimulation and three or more good
quality embryos, 16.1% had more than one child after the last FET
treatment. A live birth in fresh eSET cycle also is a good prognostic
sign, as among women having a live birth in the fresh cycle, 20.4%
had more than one child after FET(s). This means that the chance of
having more than one child is significant and should be included in
couple’s counselling information when planning eSET. As
expected, the cumulative twin birth rate was low (3.4%), which
is in line with previous research [6,14,17]. These figures are quite
reassuring, especially as a recent study showed that having IVF
twins increased the risks of preterm birth, low birth weight and
pre-eclampsia when compared with two IVF singleton pregnancies
[18].
The present study fills in a significant gap in the understanding
of infertility treatment. Cumulative data have been available in few
countries such as Finland and Sweden [3,7,8,16] which are the
countries with higher use of frozen-thawed embryo transfer
[1]. During the last decade, outcome from FET cycles has improved,
as seen for example in results from the USA [19]. This progress may
reflect improved cryopreservation protocols, but could also be a
consequence of the increased number of eSETs enabling more good
quality embryos for freezing [20]. However, cumulative results
from IVF are still not always reported even though cLBR is the best
measure of the real efficiency of the treatment protocol and should
be more widely used.
Although the results of the study give valuable information to
professionals counselling couples about eSET, some cautions
should be taken into account. The main limitation of the study
is that the data is retrospective and collected from the single clinic.
Study subjects were also younger than the typical patients of
European IVF centres. However, we believe that the results can be
generalised to clinics with experience in eSET and cryopreserva-
tion.
In conclusion, our study shows that the cumulative outcome of
eSET in women younger than 36 depends mostly on the embryo
quality. The use of eSET strategy results in excellent take-baby-
home ratios when embryo freezing is used actively. Also, according
to our analyses couples with eSET have a relatively good chance of
having more than one child following single OPU if the quality of
embryos is good. When having three or more top embryos, every
fifth woman had more than one child using embryos from the same
stimulation with a low twin rate. This novel information is useful
and reassuring for the patients when counselling and choosing the
most appropriate approach (eSET versus double embryo transfer)
in IVF.
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